AudioScholar Endocrinology Weekly

AudioScholar
  • 0.0 (0)
  • Medicine
  • Updated Weekly

Endocrinology — a weekly podcast briefing of the most significant peer-reviewed endocrinology literature, synthesized from PubMed and delivered as ~10-minute audio. For practicing physicians. Generated by AudioScholar at audioscholar.cc.

  1. 5d ago

    This Week in Endocrinology — Sep 9, 2026

    Welcome to This Week in Endocrinology. This week we're covering 10 notable papers spanning diabetes complications and how we might actually modify them, the messy practicalities of cortisol testing and adrenal surgery, and the shifting landscape of r… This week's papers: 1. Associations between fenofibrate use and sight-threatening diabetic retinopathy in type 2 diabetes: UK real-world evidence. — Journal of Clinical Endocrinology & Metabolism 2026 2. Evaluating Improvement in Pain and Sensory Function When Using High-Frequency (10-kHz) Spinal Cord Stimulation in Individuals With Painful Diabetic Neuropathy:… — Diabetes Care 2026 3. SGLT Inhibitors for Heart and Kidney Disease in Type 1 Diabetes. — Diabetes Care 2026 4. Clinical and pharmacological determinants of serum dexamethasone concentrations during dexamethasone suppression test. — Journal of Clinical Endocrinology & Metabolism 2026 5. Approach to the Patient: Diagnosis and Management of Cushing's Syndrome in the Elderly - How Different Is It? — Journal of Clinical Endocrinology & Metabolism 2026 6. Glucocorticoid Replacement Duration After Unilateral Adrenalectomy for Mild Autonomous Cortisol Secretion and Adrenal Cushing Syndrome: A Multicenter Cohort St… — European Journal of Endocrinology 2026 7. Hypoparathyroidism: translating science from the laboratory to the clinic. — The Lancet Diabetes & Endocrinology 2026 8. Hospitalizations and outcomes in Congenital Adrenal Hyperplasia across the lifespan: A population-based cohort study. — Journal of Clinical Endocrinology & Metabolism 2026 9. Obesity science, research gaps, and opportunities in the new era of obesity medicines: an Endocrine Society scientific statement. — Endocrine Reviews 2026 10. Social inequalities in gestational diabetes prevalence and complication burden: a nationwide Swedish cohort study. — Journal of Clinical Endocrinology & Metabolism 2026 Listen at https://audioscholar.cc/episode/rebust625x

  2. Sep 3

    This Week in Endocrinology — Sep 2, 2026

    Welcome to This Week in Endocrinology. This week we're covering 10 notable papers spanning obesity pharmacotherapy and weight loss as disease modification, diabetes safety and diet, and a cluster of papers across thyroid, adrenal and pituitary diseas… This week's papers: 1. Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists and Co-agonists for Weight Loss Among Adults Without Diabetes : An Updated Systematic Review. — Annals of Internal Medicine 2026 2. From adiposity to multisystem morbidity: the case for weight loss as disease modification. — The Lancet Diabetes & Endocrinology 2026 3. Ketoacidosis with SGLT2 inhibitors in routine clinical practice of type 2 diabetes: Scandinavian cohort and nested case-control study. — The Lancet Diabetes & Endocrinology 2026 4. The Minimum Frequency of Well-Day Capillary Blood Ketone Testing Needed to Predict 1-Month Diabetic Ketoacidosis Risk in Type 1 Diabetes. — Diabetes Care 2026 5. Effects of the DASH4D Diet on Biomarkers of Glycemia in Adults With Type 2 Diabetes: A Secondary Analysis of the DASH4D Randomized Clinical Trial. — Diabetes Care 2026 6. Association between antibiotic use and Graves' disease: A cohort study. — European Journal of Endocrinology 2026 7. TSH-Lowering Levothyroxine Therapy Is Associated with Higher rT3 and Stable fT3 Levels in Euthyroid Patients with Papillary Thyroid Microcarcinoma During Activ… — Thyroid 2026 8. Macrolide-Induced Aldosterone Suppression as a Functional Marker of KCNJ5-Mutated Aldosterone-Producing Adenoma: A Proof-of-Concept Clinical and Experimental S… — European Journal of Endocrinology 2026 9. Metyrapone-Associated Improvements in Health-Related Quality of Life in Cushing's Syndrome. — European Journal of Endocrinology 2026 10. Long-acting growth hormone: An updated Growth Hormone Research Society consensus statement. — European Journal of Endocrinology 2026 Listen at https://audioscholar.cc/episode/tmfadyekjp

  3. Aug 26

    This Week in Endocrinology — Aug 25, 2026

    Welcome to This Week in Endocrinology. This week we're covering 10 notable papers spanning obesity pharmacotherapy and the new dual-agonist era, diabetes therapeutics from novel oral agents to immunotherapy, and a cluster of thyroid, adrenal and rare… This week's papers: 1. Adult Overweight and Obesity Management: Updates From the 2025 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guidelines — Annals of Internal Medicine 2026 2. The evolution of new approaches to the treatment of congenital adrenal hyperplasia — Endocrine Reviews 2026 3. Efficacy and safety of mazdutide in adults with obesity or overweight: a US-based, multicentre, phase 2, randomised, placebo-controlled clinical trial — The Lancet Diabetes & Endocrinology 2026 4. Cardiometabolic Effects of Dual GLP-1 and Glucagon Receptor Agonists: A Systematic Review and Meta-analysis of Randomized Controlled Trials — Diabetes Care 2026 5. Teprotumumab Effects on Thyroid Eye Disease in a Japanese MRI Study: Comparison with Intravenous Glucocorticoid Therapy — Journal of Clinical Endocrinology & Metabolism 2026 6. Diagnosis of hypochondroplasia: international Delphi consensus recommendations — Nature Reviews Endocrinology 2026 7. A Randomized Placebo-Controlled Trial of HTD1801 Monotherapy in Participants With Type 2 Diabetes — Diabetes Care 2026 8. β-Cell Function and Diabetes Outcomes 1 Year After Stopping Oral Baricitinib Immunotherapy for Type 1 Diabetes — Diabetes Care 2026 9. Octreotide as Adjunctive Therapy for Catecholamine-Secreting Pheochromocytoma and Paraganglioma — Journal of Clinical Endocrinology & Metabolism 2026 10. Pregnancy after Hemithyroidectomy: Increased Risk of Gestational Overt Hypothyroidism Despite Favorable Obstetric Outcomes: A Nationwide Study — Thyroid 2026 Listen at https://audioscholar.cc/episode/kut6wzd9bs

  4. Aug 19

    This Week in Endocrinology — Aug 18, 2026

    Welcome to This Week in Endocrinology. This week we're covering 10 notable papers spanning new frontiers in type 2 diabetes pharmacotherapy, precision genetics and personalised care across the diabetes spectrum, and long-term risk in survivors — from… This week's papers: 1. Once-weekly IcoSema versus once-daily insulin glargine U100 in type 2 diabetes management (COMBINE 4): an open-label, multicentre, treat-to-target, randomised,… — The Lancet Diabetes & Endocrinology 2026 2. Long-term safety of oral orforglipron in Japanese participants with type 2 diabetes (ACHIEVE-J): a multicentre, randomised, open-label, parallel-group phase 3… — The Lancet Diabetes & Endocrinology 2026 3. SGLT-2 inhibitors and risk of 59 long-term health conditions, hospitalisation, and mortality — European Journal of Endocrinology 2026 4. The liver in diabetes: current state and future perspectives — Diabetologia 2026 5. Precision Medicine in patients with rare forms of genetic obesity: Necessity for coordinated and structured care — Journal of Clinical Endocrinology & Metabolism 2026 6. A multi-centre study of belatacept and sirolimus for islet transplantation — Diabetologia 2026 7. Adult Complications of Childhood-Onset Type 1 Diabetes Vary With Age at Diagnosis: A Population-Based Study — Diabetes Care 2026 8. Clinical Utility of a Type 1 Diabetes Genetic Risk Score Measured as Part of MODY Genetic Testing — Diabetes Care 2026 9. Efficacy and Safety of Time-Restricted Eating in Adults With Type 1 Diabetes: A Randomized Controlled Trial — Diabetes Care 2026 10. Second Primary Malignancies Among Pediatric and Young Adult Survivors of Differentiated Thyroid Cancer: Real-World Evidence — Thyroid 2026 Listen at https://audioscholar.cc/episode/c43gszq3n2

  5. Aug 12

    This Week in Endocrinology — Aug 11, 2026

    Welcome to This Week in Endocrinology. This week we're covering 10 notable papers spanning the expanding cardio-kidney-metabolic reach of incretin therapy and weight loss, adrenal and pituitary disease from diagnostic testing to targeted oncology, an… This week's papers: 1. Effect of semaglutide on kidney outcomes in the SELECT, FLOW, and SOUL trials: a prespecified pooled analysis. — The Lancet Diabetes & Endocrinology 2026 2. Early Weight Loss in Impaired Glucose Tolerance Is Associated With Reduced Long-term Mortality and Cardiovascular Risk: The Da Qing Diabetes Prevention Outcome… — Diabetes Care 2026 3. Impact of adrenalectomy on metabolic alterations and quality of life in mild autonomous cortisol secretion: results from the randomized CHIRACIC trial. — European Journal of Endocrinology 2026 4. Efficacy and safety of once-weekly semaglutide 2.4 mg in Chinese adults with overweight or obesity (STEP 12): a randomised, double-blind, placebo-controlled, m… — The Lancet Diabetes & Endocrinology 2026 5. Belzutifan, A Hypoxia-Inducible Factor 2-Alpha Inhibitor, for Patients with Advanced Pheochromocytoma and Paraganglioma. — Journal of Clinical Endocrinology & Metabolism 2026 6. Decision Tree Prediction of Saline Infusion Test Outcomes in Suspected Primary Aldosteronism: A Multicenter CDM Study. — Journal of Clinical Endocrinology & Metabolism 2026 7. Gestational Diabetes Mellitus: Recurrence and Future Type 2 Diabetes Risk Across Racial and Ethnic Groups. — Diabetes Care 2026 8. Management of Cirrhosis in Diabetes: A Pragmatic Approach to the Patient. — Journal of Clinical Endocrinology & Metabolism 2026 9. Cardiovascular morbidity and mortality in acromegaly-associated diabetes: a Swedish Nationwide study. — Journal of Clinical Endocrinology & Metabolism 2026 10. Temple syndrome - an under-recognised multi-system growth disorder: large cohort analysis and proposed scoring system. — Journal of Clinical Endocrinology & Metabolism 2026 Listen at https://audioscholar.cc/episode/upjt6gujuq

  6. Aug 5

    This Week in Endocrinology — Aug 4, 2026

    Welcome to This Week in Endocrinology. This week we're covering ten notable papers spanning pediatric and genetic endocrinology, diabetes care and risk prediction, and novel management strategies in thyroid and adrenal diseases. Let's dive in. We be… This week's papers: 1. Once-weekly somapacitan enhances linear growth in girls with Turner syndrome: a randomized controlled phase 3 study. — The Journal of clinical endocrinology and metabolism 2026 2. Continuous Glucose Monitoring in Type 2 Diabetes and Beyond: A Review. — JAMA internal medicine 2026 3. Pharmacokinetics of inhaled prednisolone for adrenal crisis: an exploratory study. — European journal of endocrinology 2026 4. Safety of glucagon-like peptide-1 receptor agonists in neuroendocrine neoplasms. — European journal of endocrinology 2026 5. Micro-Costing Analysis of Thyroid Radiofrequency Ablation Compared with Hemithyroidectomy in Outpatient and Inpatient Settings. — Thyroid 2026 6. Is MASLD an independent risk factor for micro- and macrovascular complications of diabetes? A critical reappraisal and future directions. — Diabetologia 2026 7. Predicting future risk of type 1 and type 2 diabetes after gestational diabetes mellitus using polygenic scores: a cohort study. — Diabetologia 2026 8. Maternal Third-Trimester TRAb Is Associated with Neonatal Thyroid Dysfunction and 24-Month Offspring Neurodevelopment: A Bidirectional Cohort Study. — Thyroid 2026 9. Prognostic Stratification of Brain Metastases from Nonanaplastic Follicular Cell-Derived Thyroid Carcinoma: Results of an International Multicenter Retrospecti… — Thyroid 2026 10. Melanocortin-4 Receptor Regulation of Endocrine Axes and Clinical Effects of Setmelanotide. — The Journal of clinical endocrinology and metabolism 2026 Listen at https://audioscholar.cc/episode/knpm8jvjvj

  7. Jul 31

    This Week in Endocrinology — Jul 31, 2026

    Welcome to This Week in Endocrinology. This week we are covering ten notable papers spanning novel dual-acting incretin therapies and vascular diagnostics in diabetes, long-term management and complications in type 1 diabetes, and advanced diagnostic… This week's papers: 1. Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomi… — Lancet 2026 2. Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, rand… — Lancet 2026 3. Diagnostic Tools to Establish the Presence of Peripheral Arterial Disease in People With Diabetes (DMPAD): A Multicenter Comparative Diagnostic Accuracy Study. — Diabetes Care 2026 4. KCNJ5-Dependent 68Ga-Pentixafor PET/CT in Primary Aldosteronism Surgery. — The Journal of Clinical Endocrinology and Metabolism 2026 5. Insulin Pump Use and Hospital Outcomes in Adults With Type 1 Diabetes: A 2022 Nationwide Readmissions Database Analysis. — The Journal of Clinical Endocrinology and Metabolism 2026 6. Type 1 diabetes in older populations. — The Lancet Diabetes & Endocrinology 2026 7. Low measured free testosterone is associated with worse sexual function in community-dwelling men. — European Journal of Endocrinology 2026 9. Cardiac autonomic neuropathy predicts renal decline in type 1 diabetes mellitus: a 15 year follow-up study. — Diabetologia 2026 10. Application of Theranostics in Thyroid Cancer Management. — The Journal of Clinical Endocrinology and Metabolism 2026 Listen at https://audioscholar.cc/episode/fy9jf3rkjm

  8. Jul 22

    This Week in Endocrinology — Jul 21, 2026

    Welcome to This Week in Endocrinology. This week we're covering 5 notable papers spanning diabetes cardiovascular outcomes, the management and safety of antithyroid drug therapy, and the long-term systemic mental health burdens of endocrine disorders… This week's papers: 1. Oral Semaglutide and CV Benefits in the SOUL Trial: How Do Baseline or Changes in HbA1c or BMI Affect Clinical Outcomes? — The Journal of clinical endocrinology and metabolism 2026 2. Shorter Versus Standard Antithyroid Drug Therapy in Graves' Disease with Lower Baseline Thyrotropin Receptor Antibody (TRAb) Levels: Relapse Outcomes from a Pr… — Thyroid : official journal of the American Thyroid Association 2026 3. Depression and Anxiety in Patients with Endogenous Cushing Syndrome: A Nationwide Matched Cohort Study Using Affective Drug Dispensations. — European journal of endocrinology 2026 4. Risk of Significant Liver Enzyme Elevation After Switching Antithyroid Drugs. — European journal of endocrinology 2026 5. Methimazole-Associated Neutropenia and Agranulocytosis in Pediatric Patients with Graves' Disease: A Chinese Cohort Study. — Thyroid : official journal of the American Thyroid Association 2026 Listen at https://audioscholar.cc/episode/753g9zu7uq

See All (18)

About

Endocrinology — a weekly podcast briefing of the most significant peer-reviewed endocrinology literature, synthesized from PubMed and delivered as ~10-minute audio. For practicing physicians. Generated by AudioScholar at audioscholar.cc.

Information